新生儿红细胞增多症神经系统远期预后的研究进展  

Research Progress in the Long-term Prognosis of the Nervous System of Neonatal Polycythemia

作　　者：闫晨斐 李秋平[2] 封志纯[2] 

机构地区：[1]山西医科大学,太原030001 [2]北京军区总医院临床医学院附属八一儿童医院新生儿重症监护病房,北京100700

出　　处：《医学综述》2016年第1期94-97,共4页Medical Recapitulate

基　　金：国家自然科学基金(81270059)

摘　　要：红细胞增多症是新生儿期的常见问题,对该病的诊断和治疗,新生儿专家已达成了一致的标准,即部分换血疗法。但其远期预后,尤其是神经系统的远期预后的影响一直存在很大的争议。该文主要以新生儿红细胞增多症(NP)神经系统远期预后、部分换血疗法对神经系统远期预后的影响及NP神经系统远期预后的根本病因进行综述。Polycythemia is one of the common diseases in neonatal period. For the diagnosis and treatment of the disease neonatologists have come to an agreement,i. e. partial exchange transfusion. But there have been a lot of controversies in long-term outcome,especially of the nervous system. Here is to make a review of the long-term prognosis of the nervous system of neonatal polycythemia,long-term prognosis of partial exchange transfusion on the nervous system and the underlying cause of long-term prognosis.

关 键 词：红细胞增多症 新生儿 神经损伤 部分换血疗法 

分 类 号：R722.1[医药卫生—儿科]